BNET Industries

Alliance Pharmaceutical Corp.

(ALLP) is in the Pharma Industry

Market Cap:$673.1K
Last Fiscal Year Sales:$106.0K
  • Public
  • US
Dow Jones Description

Alliance Pharmaceutical Corp. (the "Company" or "Alliance") is a pharmaceutical research and development company that focuses on developing scientific discoveries into medical products for human health applications. Imagent(R) (formerly named Imavist(TM)), has been approved for sale in the U.S. as an intravenous contrast agent for enhancement of ultrasound images to assess cardiac structure and motion. In the past year, the Company entered into an Asset Purchase Agreement with Photogen Technologies, Inc. ("Photogen") whereby Photogen acquired all of the assets related to designing, developing, manufacturing, marketing, selling, licensing, supporting and maintaining Imagent (collectively, the "Imagent Business") and assumed certain of the Company's liabilities. Another of the Company's products, Oxygent(TM), is in clinical development as an intravascular oxygen carrier to reduce the need for donor blood in surgical and other patients at risk of acute tissue hypoxia (oxygen deficiency). Through its 100%-owned subsidiary, Astral, Inc. ("Astral"), the Company has developed intellectual property and know-how for potential products to treat immune disorders, including autoimmune disease, cancer, and infectious diseases.

Chairman and Chief Executive OfficerDuane Roth
Number of Employees 1
Contact Information

4660 La Jolla Village Dr Ste 825

San Diego, California 92122

www.allp.com

(858) 410-5275 (Corp Comm)

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

Filter by

alliance pharmaceutical corp. - All News and Analysis

Additional Resources

  • The economics of corporate governance and mergers

    - 2009-02-01

    The economics of corporate governance and mergers. Ed. by Klaus Peter Gugler and B. Burcin Yurtoglu. Edward Elgar Publishing 2008 362 pages $170.00 Hardcover HD2741 Governance and mergers are not intrinsically linked, but are...

  • CryoPort Collaborates With Advinus Therapeutics

    - 2008-11-19

    CryoPort, Inc. (OTCBB: CYRX) todayannounced that it is collaborating with Advinus Therapeutics on commercialCryoPort ExpressTM shipments to India. The collaboration has involved shipping frozen samples from two sites inthe U.S. to Bangalore for analysis. Advinus is one of the leading R&Dalliances and pharmaceutical research outsourcing companies in India, partof...

  • JRCC, NFLX, TASR, UTSI, AEGG, ALLP Have Also Been Removed From Naked Short List Today.

    - 2008-01-04

    M2 PRESSWIRE-4 January 2008-BUYINS.NET: JRCC, NFLX, TASR, UTSI, AEGG, ALLP Have Also Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:04012008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and...

  • Covad Honored with California Innovation Award

    - 2007-04-27

    Wireless News04-27-2007Covad Honored with California Innovation AwardWIRELESS NEWS-April 27, 2007-Covad Honored with California Innovation Award C2007 10Meters - http://www.10meters.com Covad Communications Group, a national provider of integrated voice and data communications, announced that it has been recognized as one of 15 Innovation All-Stars by California Tech 100 Partners and...

  • Covad Recognized with California Innovation Award

    - 2007-04-26

    Governor Schwarzenegger's Commission for Jobs and Economic Growth Honors California's Top Businesses with Innovation Awards SAN JOSE, Calif. -- Covad Communications Group, Inc. (AMEX: DVW), a national provider of integrated voice and data communications, announced today that it has been recognized as one of 15 Innovation All-Stars by...

Decision Makers

Name (plus bio) Position
B. Jack Defranco President and Chief Operating, Officer

Board of Directors

Name (plus bio) Position
Duane Roth Chairman and Chief Executive Officer
Stephen M. McGrath Audit Committee Chairman
Caroll O. Johnson Board of Directors
Carroll O Johnson Board of Directors
Jean Riess Board of Directors
Pedro Cuatrecasas Board of Directors
Theodore D. Roth Board of Directors
Organization Position Status
UCSD-CONNECT Chief Executive Officer Current
Alliance Pharmaceutical Corp Chairman and Chief Executive Officer Current
UCSD-CONNECT Director Current
University of California Board Member Current
San Diego Regional Chamber of Commerce Board Member Current
Alliance Pharmaceutical Corp Founder Former
Johnson & Johnson Senior Management Positions Former
American Home Products Corporation Senior Management Positions Former
The San Diego Foundation Board of Directors Former
Biotechnology Industry Organization Director Former
Biocom, Inc. Board of Directors Former
California Healthcare Institute, Inc. Director Former
Organization Position Status
Alliance Pharmaceutical Corp President and Chief Operating, Officer Current
Imcor Pharmaceutical Co Chief Operating Officer Former
Imcor Pharmaceutical Co Senior Vice President Former
Fairleigh Dickinson University Masters In Finance Former
Stephen F. Austin State University BS In Biology Former
Organization Position Status
Alliance Pharmaceutical Corp Audit Committee Chairman Current
Sterling Drug Controller Former
Sterling Drug Assistant Treasurer Former
Warner-Lambert Former
Warner-Lambert Company Former
Sterling Drug Board of Directors Former
Organization Position Status
Alliance Pharmaceutical Corp Board of Directors Current
Organization Position Status
Alliance Pharmaceutical Corp Board of Directors Current
Organization Position Status
Alliance Pharmaceutical Corp Board of Directors Current

PEDRO CUATRECASAS, M.D. Dr. Cuatrecasas has served as a director of the Company since August 1996. He has over 35 years of experience in the pharmaceutical industry. Dr. Cuatrecasas retired from the positions of Vice President of Warner-Lambert Company and President, Parke-Davis Pharmaceutical Research on December 31, 1996, positions he had held since 1989. During the previous four years, he had been Senior Vice President of Research and Development and Director of Glaxo, Inc. For the prior ten years, he was Vice President of Research, Development and Medical and Director of Burroughs Wellcome Company. Dr. Cuatrecasas is a member of the National Academy of Sciences and the Institute of Medicine. He is currently an independent consultant in pharmaceutical research and an Adjunct Professor in Medicine and Pharmacology at the University of California in San Diego. He received his M.D. from Washington University School of Medicine. Dr. Cuatrecasas qualifies as an "independent" director within the meaning of Rule 4200(a)(15) of the NASD Listing Standards.

Organization Position Status
University of California Adjunct Professor Current
Mehta Partners - Global Healthcare Investments Current
National Academy of Sciences Board of Directors Current
Alliance Pharmaceutical Corp Board of Directors Current
Aethlon Medical, Inc. Board of Directors Current
National Academy of Sciences Member Current
Burroughs Wellcome Co. - USA Vice President of Research and Development Former
Burroughs Wellcome Co. - USA Director Former
Washington University School of Medicine M.D. Former
Washington University M.D. (Magna Cum Laude) Former

Ted Roth joined Roth Capital Partners in 2003, following 15 years with Alliance Pharmaceutical Corp., a publicly-owned specialty pharmaceutical development company, most recently serving as President and Chief Operating Officer. On behalf of the company, he negotiated and executed several multi-million dollar collaborations, acquisitions, and divestitures, as well as public and private financing transactions. Prior to Alliance, he spent 10 years with a privately-held manufacturing company in various financial and management positions. He is on the Board of Directors of Alliance Pharmaceutical and BioMed Realty Trust, Inc (NYSE:BMR). Mr. Roth is also a member of the Boards of Directors of the San Diego Regional Chamber of Commerce (2002 Chairman), San Diego Children's Hospital & Health Center, the San Diego Padres Baseball Team, San Diego International Sports Council (2005 Chairman), the Pacific Life Holiday Bowl, BIOCOM/San Diego, and High Tech High School. He is past Chair of the California Democratic Leadership Council. He is a graduate of Iowa Wesleyan College, and has a J.D. from Washburn University and an LL.M. from the University of Missouri in Kansas City.

Organization Position Status
Roth Capital Partners LLC President and Chief Operating Officer Current
San Diego Regional Chamber of Commerce Special Team Current
Bmr Inc Board of Directors Current
UCSD-CONNECT Director Current
San Diego Regional Chamber of Commerce Board Director Current
Edvoice.Org Board of Directors Current
Alliance Pharmaceutical Corp Board of Directors Current
BioMed Realty Trust, Inc. Director Current
Padres L.P. Board of Directors Current
Orange 21 Inc. Board of Directors Current
Padres L.P. Member Current
San Diego International Sports Council Member Current
Alliance Pharmaceutical Corp President Former
Roth Capital Partners LLC Managing Director Former
San Diego International Sports Council Board Member Former
Pacific Life Holiday Bowl Board Member Former
Washburn University Juris Doctor Degree Former
University of Missouri Master of Laws In Corporate and Commercial Law Former
University of Missouri-Kansas City LL.M Former

Executive News

  • We aren't going to have many smart people left once they start hacking and slashing education.

    Voice of San Diego - 5/29/09 - View Story

  • Innovation Lost? State's Budget Takes its Toll on Tech

    Voice of San Diego - 5/29/09 - View Story

advertisement
     ALLP $0.01 +0.00 (25.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 165,239
Shares Outstanding 67.32M
Market Cap 673.2K
Year High 0.03
Year Low 0.002
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
Glass Door

Pharma Industry Companies

Company Employer Rating
Pfizer 3.0
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement